Dennis Fitzgerald

Title: Dennis Fitzgerald: Innovator in Psoriasis Treatment

Introduction

Dennis Fitzgerald is a notable inventor based in Spring House, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of psoriasis. His innovative approach has led to the development of a unique method that addresses the needs of patients who have not responded adequately to previous treatments.

Latest Patents

Fitzgerald holds a patent for a method of treating psoriasis with an anti-IL23 specific antibody. This method involves administering an IL-23 specific antibody, such as guselkumab, to patients who have previously been treated with an IL-12/23p40 antibody and have been determined to be inadequate responders. The treatment aims for the patient to achieve a PASI75, PASI90, PASI100, or IGA 0 or 1 score, as measured at various intervals after the initial treatment.

Career Highlights

Dennis Fitzgerald is associated with Janssen Biotech, Inc., where he continues to work on innovative solutions for challenging medical conditions. His dedication to improving patient outcomes is evident in his research and development efforts.

Collaborations

Fitzgerald has collaborated with esteemed colleagues, including Newman Yeilding and Jay Siegel, to advance his work in the field of psoriasis treatment. Their combined expertise contributes to the ongoing development of effective therapies.

Conclusion

Dennis Fitzgerald's contributions to the treatment of psoriasis through his patented method highlight his commitment to innovation in medicine. His work not only addresses the needs of patients but also sets a precedent for future advancements in the field.